Self-described weed fiend Seth Rogen is getting in the cannabis game with the launch of his own pot company, Houseplant, into the California market.

The Canadian company he co-founded will sell three different strains including Pancake Ice sativa, which has more than 30 per cent THC.

Given that Rogen co-wrote (and starred in) pot comedy Pineapple Express, it’s fair to say prospective customers won’t be expecting any old reggie weed from the California market’s newest competitor.

An NBC report said the website for Houseplant (which was founded in 2019) crashed after Rogen aired his US distribution announcement on Twitter.

The incoming Biden administration has given renewed vigour to talks of further legalisation measures gaining steam in the US market.

And Seth Rogen isn’t the only celebrity sensing a market opportunity.

Rapper Snoop Dogg is the co-founder of Casa Verde Capital, which reportedly has cannabis-adjacent holdings north of $US200m.

Amid that bullish outlook, Stockhead caught up this week with cannabis investor Mark Bernberg who said he’s particularly focused on investment opportunities in the US market.

While Australian companies are restricted to focusing on medicinal cannabis solutions, Bernberg said recreational THC products in the US will be more lucrative in the near-term — particularly for companies that have cut through the early hype phase to establish viable business models.

Closer to home, local pot stocks cooled off last week as 30 of the 36 cannabis (and cannabis adjacent) companies tracked by Stockhead posted a weekly loss.

Over the last month though, returns were more stellar as 15 companies gained ground, led by MGC Pharmaceuticals (ASX:MXC) which rose by more than 200 per cent.

The latest weekly, monthly and annual price performance for ASX-listed cannabis stocks:

Scroll or swipe to reveal table. Click headings to sort.

Code Name Price ($) 1W % Ret 1M % Ret 1Y % Ret Market Cap
RNO Rhinomed Ltd 0.13 8.3% 0.0% -13.3% $31.7M
EPN Epsilon Healthcare 0.24 2.1% 4.3% -22.6% $42.6M
YPB YPB Group Ltd 0.0025 0.0% 0.0% -16.7% $14.2M
ESE Esense-Lab Ltd 0.018 0.0% 0.0% 200.0% $9.2M
DTZ Dotz Nano Ltd 0.24 0.0% 0.0% 328.6% $90.3M
APH AP Hemp Ltd 0.465 0.0% 9.4% 257.7% $32.8M
LGP Little Green Pharma 0.685 -0.7% -13.3% 80.3% $86.8M
WOA Wide Open Agricultur 0.69 -1.4% -6.1% 475.0% $65.8M
AGH Althea Group 0.515 -2.8% 13.2% 83.9% $136.4M
MRG Murray River Grp 0.33 -2.9% -17.5% -70.3% $15.7M
ECS ECS Botanics Holding 0.063 -4.5% 34.0% 75.0% $29.6M
LV1 Live Verdure Ltd 0.2 -4.8% 5.3% 0.0% $8.4M
CAN Cann Group Ltd 0.625 -5.3% -0.8% -26.5% $166.9M
CGB Cann Global Limited 0.0085 -5.6% -15.0% -15.0% $46.3M
MDC Medlab Clinical Ltd 0.325 -5.8% 8.3% 47.7% $90.0M
BDA Bod Australia 0.44 -7.4% -2.2% 91.3% $46.6M
LSH Lifespot Health Ltd 0.125 -7.4% 4.2% 290.2% $21.1M
MMJ MMJ Group Hlds Ltd 0.125 -7.4% 8.7% 43.7% $28.7M
ROO Roots Sustainable 0.021 -8.7% 5.0% -8.7% $10.8M
RGI Roto-Gro Intl Ltd 0.052 -8.8% -3.7% -52.7% $12.3M
IDT IDT Australia Ltd 0.19 -9.5% -7.3% 58.3% $44.4M
SCU Stemcell United Ltd 0.028 -9.7% 75.0% 133.3% $22.7M
CAU Cronos Australia 0.14 -9.7% -3.4% -6.7% $6.8M
SUD Suda Pharmaceuticals 0.046 -9.8% 2.2% -8.0% $17.3M
BOT Botanix Pharma Ltd 0.11 -10.4% -25.9% 49.3% $107.0M
CP1 Cannpal Animal 0.165 -10.8% -8.3% 37.5% $14.9M
ZLD Zelira Therapeutics 0.069 -11.5% -12.7% 68.3% $80.9M
CPH Creso Pharma Ltd 0.2 -12.0% -3.6% 153.1% $195.5M
EXL Elixinol Global 0.2 -13.0% 8.1% -41.3% $61.2M
AC8 Auscann Grp Hlgs Ltd 0.15 -14.3% -14.3% -28.6% $49.1M
NTI Neurotech Intl 0.065 -14.5% 54.8% 983.3% $35.3M
IHL Incannex Healthcare 0.2 -14.9% 21.2% 344.4% $216.1M
PAL Palla Pharma Ltd 0.55 -15.6% -6.7% -27.7% $75.6M
EOF Ecofibre Limited 1.26 -16.3% -29.5% -45.2% $187.3M
EVE EVE Investments Ltd 0.0065 -18.8% -18.8% 44.4% $26.9M
MXC MGC Pharmaceuticals 0.081 -22.9% 211.5% 224.0% $178.3M